Poolbeg Pharma PLC (AIM:POLB)
London · Delayed Price · Currency is GBP · Price in GBX 4.400
-0.100 (-2.22%)
May 6, 2026, 4:10 PM GMT
Poolbeg Pharma Market Cap
Poolbeg Pharma has a market cap or net worth of 31.73 million as of May 6, 2026. Its market cap has increased by 135.03% in one year.
Market Cap
31.73M
Enterprise Value
24.02M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
4.40
Market Cap Chart
Since July 19, 2021, Poolbeg Pharma's market cap has decreased from 53.75M to 31.73M, a decrease of -40.97%. That is a compound annual growth rate of -10.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 31.73M | 13.78% |
| Dec 31, 2025 | 27.89M | -21.44% |
| Dec 31, 2024 | 35.50M | -21.55% |
| Dec 29, 2023 | 45.25M | 49.59% |
| Dec 30, 2022 | 30.25M | -36.32% |
| Dec 31, 2021 | 47.50M | -11.63% |
| Jul 19, 2021 | 53.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ondine Biomedical | 61.05M |
| hVIVO | 50.15M |
| Hemogenyx Pharmaceuticals | 43.47M |
| Sareum Holdings | 27.96M |
| ImmuPharma | 25.83M |
| SkinBioTherapeutics | 25.27M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 21.59M |